Skip to main content

I Sjaastad

First name:
I
Last name:
Sjaastad
Manotheepan, R., Danielsen, T., Sadredini, M., Anderson, M., Carlson, C., Lehnart, S., … Stokke, M. (2016). Exercise training prevents ventricular tachycardia in CPVT1 due to reduced CaMKII-dependent arrhythmogenic Ca2+ release. Cardiovascular Research, 111(3), 295-306. https://doi.org/10.1093/cvr/cvw095 (Original work published 2016)
Lunde, I., Aronsen, J., Melleby, A., Strand, M., Skogestad, J., Bendiksen, B., … Christensen, G. (2022). Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy. Molecular Biology Reports. https://doi.org/10.1007/s11033-022-07985-y (Original work published 2022)
Støle, T., Lunde, M., Shen, X., Martinsen, M., Lunde, P., Li, J., … Carlson, C. The female syndecan-4<sup>-/-</sup> heart has smaller cardiomyocytes, augmented insulin/pSer473-Akt/pSer9-GSK-3β signaling, and lowered SCOP, pThr308-Akt/Akt and GLUT4 levels. Frontiers in Cell and Developmental Biology, 10, 908126. https://doi.org/10.3389/fcell.2022.908126 (Original work published 2022)
Carlson, C., Aronsen, J., Bergan-Dahl, A., Moutty, M., Lunde, M., Lunde, P., … Sejersted, O. (2022). AKAP18δ Anchors and Regulates CaMKII Activity at Phospholamban-SERCA2 and RYR. Circulation Research, 130(1), 27-44. https://doi.org/10.1161/CIRCRESAHA.120.317976 (Original work published 2022)
Wanichawan, P., Skogestad, J., Lunde, M., Støle, T., Stensland, M., Nyman, T., … Carlson, C. Design of a Proteolytically Stable Sodium-Calcium Exchanger 1 Activator Peptide for <i>In Vivo</i> Studies. Frontiers in Pharmacology, 12, 638646. https://doi.org/10.3389/fphar.2021.638646 (Original work published 2021)
Rønning, S., Carlson, C., Aronsen, J., Pisconti, A., , Lunde, M., … Pedersen, M. Syndecan-4<sup>-/-</sup> Mice Have Smaller Muscle Fibers, Increased Akt/mTOR/S6K1 and Notch/HES-1 Pathways, and Alterations in Extracellular Matrix Components. Frontiers in Cell and Developmental Biology, 8, 730. https://doi.org/10.3389/fcell.2020.00730 (Original work published 2020)
Herum, K., Romaine, A., Wang, A., Melleby, A., Strand, M., Pacheco, J., … Christensen, G. (2020). Syndecan-4 Protects the Heart From the Profibrotic Effects of Thrombin-Cleaved Osteopontin. Journal of the American Heart Association, 9(3), e013518. https://doi.org/10.1161/JAHA.119.013518 (Original work published 2020)
Mathiesen, S., Lunde, M., Aronsen, J., Romaine, A., Kaupang, A., Martinsen, M., … Carlson, C. (2019). The cardiac syndecan-4 interactome reveals a role for syndecan-4 in nuclear translocation of muscle LIM protein (MLP). The Journal of Biological Chemistry, 294(22), 8717-8731. https://doi.org/10.1074/jbc.RA118.006423 (Original work published 2019)
Skogestad, J., Aronsen, J., Tovsrud, N., Wanichawan, P., Hougen, K., Stokke, M., … Swift, F. (2020). Coupling of the Na+/K+-ATPase to Ankyrin B controls Na+/Ca2+ exchanger activity in cardiomyocytes. Cardiovascular Research, 116(1), 78-90. https://doi.org/10.1093/cvr/cvz087 (Original work published 2020)
Ottesen, A., Carlson, C., Eken, O., Sadredini, M., Myhre, P., Shen, X., … Louch, W. (2019). Secretoneurin Is an Endogenous Calcium/Calmodulin-Dependent Protein Kinase II Inhibitor That Attenuates Ca<sup>2+</sup>-Dependent Arrhythmia. Circulation. Arrhythmia and Electrophysiology, 12(4), e007045. https://doi.org/10.1161/CIRCEP.118.007045